Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Andrew R. Branagan(Massachusetts General Hospital), Madhav V. Dhodapkar(Yale Cancer Center), Daniel Zelterman(Yale University), Jeremy Kortmansky(Yale Cancer Center), Connor Foster(Yale Cancer Center), Geliang Gan(Yale University), David H. Witt(Yale Cancer Center), Lin Zhang(Yale Cancer Center), Rakesh Verma(Harvard University), Thomas Ferencz(Yale Cancer Center), Stuart Seropian(Yale Cancer Center), Eamon Duffy(Auckland City Hospital), Terri L. Parker(Yale Cancer Center), Debra Brandt(Yale Cancer Center)
Blood
December 2, 2016
Cited by 2


Related Papers